News
A Single Shot of an Antibody Treatment Against #COVID19 Developed by #UK Drug Major ... - Latest Tweet by IANS India
The latest Tweet by IANS India states, 'A single shot of an antibody treatment against #COVID19 developed by #UK drug major #AstraZeneca is 83 per cent capable to reduce the risk of the infectious disease compared to placebo, according to new clinical trial results.'
A single shot of an antibody treatment against #COVID19 developed by #UK drug major #AstraZeneca is 83 per cent capable to reduce the risk of the infectious disease compared to placebo, according to new clinical trial results. pic.twitter.com/W1C9rS7yk4— IANS Tweets (@ians_india) November 19, 2021
(The above story first appeared on LatestLY on Nov 19, 2021 06:56 PM IST. For more news and updates on politics, world, sports, entertainment and lifestyle, log on to our website latestly.com).
